POLE c.4913A>G ;(p.N1638S)

Variant ID: 12-133219131-T-C

NM_006231.2(POLE):c.4913A>G;(p.N1638S)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Afatinib treatment response in advanced lung adenocarcinomas harboring uncommon mutations.

Thoracic Cancer
Li, Teng T; Wang, Shouzheng S; Ying, Jianming J; Wang, Yan Y; Hu, Xingsheng X; Hao, Xuezhi X; Xu, Ziyi Z; Xing, Puyuan P; Li, Junling J
Publication Date: 2021-11

Variant appearance in text: POLE: N1638S
PubMed Link: 34549528
Variant Present in the following documents:
  • Main text
  • TCA-12-2924.pdf
View BVdb publication page



Afatinib treatment response in advanced lung adenocarcinomas harboring uncommon mutations.

Thoracic Cancer
Li, Teng T; Wang, Shouzheng S; Ying, Jianming J; Wang, Yan Y; Hu, Xingsheng X; Hao, Xuezhi X; Xu, Ziyi Z; Xing, Puyuan P; Li, Junling J
Publication Date: 2021-11

Variant appearance in text: POLE: N1638S
PubMed Link: 34549528
Variant Present in the following documents:
  • Main text
  • TCA-12-2924.pdf
View BVdb publication page



A computational and structural analysis of germline and somatic variants affecting the DDR mechanism, and their impact on human diseases.

Scientific Reports
Magraner-Pardo, Lorena L; Laskowski, Roman A RA; Pons, Tirso T; Thornton, Janet M JM
Publication Date: 2021-07-12

Variant appearance in text: POLE: 4913A>G; Asn1638Ser; rs771399151
PubMed Link: 34253785
Variant Present in the following documents:
  • 41598_2021_93715_MOESM2_ESM.xlsx, sheet 8
View BVdb publication page